Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.

[1]  J. Calixto,et al.  Anti-inflammatory properties of extracts, fractions and lignans isolated from Phyllanthus amarus. , 2005, Planta medica.

[2]  J. McHowat,et al.  Phospholipase A2 inhibitors as potential anti-inflammatory agents. , 2005, Current pharmaceutical design.

[3]  J. Young,et al.  Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents , 1989, Agents and Actions.

[4]  P. Bessin,et al.  Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes , 1981, Agents and Actions.

[5]  N. Morioka,et al.  Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice , 2004, Pain.

[6]  J. Calixto,et al.  Anti-allodynic and anti-oedematogenic properties of the extract and lignans from Phyllanthus amarus in models of persistent inflammatory and neuropathic pain. , 2003, European journal of pharmacology.

[7]  R. Kuttan,et al.  Inhibition of experimental gastric lesion and inflammation by Phyllanthus amarus extract. , 2003, Journal of ethnopharmacology.

[8]  A. Vollmar,et al.  Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-kappaB pathway. , 2003, Journal of hepatology.

[9]  S. C. Hess,et al.  Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice. , 2002, European journal of pharmacology.

[10]  R. Yunes,et al.  Antinociceptive properties of extracts of new species of plants of the genus Phyllanthus (Euphorbiaceae). , 2000, Journal of ethnopharmacology.

[11]  M. Wilson,et al.  Platelet-activating factor and bacteremia-induced pulmonary hypertension. , 2000, The Journal of surgical research.

[12]  S. Ishii,et al.  Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. , 2000, Progress in lipid research.

[13]  K. Ahn,et al.  Structure-activity relationships of lignans from Schisandra chinensis as platelet activating factor antagonists. , 1999, Biological & pharmaceutical bulletin.

[14]  R. Yunes,et al.  A review of the plants of the genus Phyllanthus: Their chemistry, pharmacology, and therapeutic potential , 1998, Medicinal research reviews.

[15]  I. Lee,et al.  Magnone A and B, novel anti-PAF tetrahydrofuran lignans from the flower buds of Magnolia fargesii. , 1998, Journal of natural products.

[16]  M. Webb,et al.  A novel class of non-peptidic endothelin antagonists isolated from the medicinal herb Phyllanthus niruri , 1995 .

[17]  M. Martins,et al.  Yangambin: A New Naturally-Occurring Platelet-Activating Factor Receptor Antagonist: Binding and In Vitro Functional Studies , 1995, Planta medica.

[18]  G. Webster,et al.  Usage and bioassays in Phyllanthus (Euphorbiaceae). IV. Clustering of antiviral uses and other effects. , 1995, Journal of ethnopharmacology.

[19]  H. Bito,et al.  Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. , 1991, The Journal of biological chemistry.

[20]  O. Gottlieb.  The rational search for natural neolignans. , 1991, Memorias do Instituto Oswaldo Cruz.

[21]  P. Braquet,et al.  Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. , 1990, The Journal of biological chemistry.

[22]  M. Martins,et al.  Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse , 1990, British journal of pharmacology.

[23]  P. Braquet,et al.  Interactions of arachidonic acid metabolites and platelet activating factor and mechanism of action in hypersensitivity reactions. , 1987, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[24]  X. Wang,et al.  The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor. , 1985, International journal of tissue reactions.

[25]  G. Towers,et al.  Biological activities of lignans , 1984 .

[26]  E. J. Ariëns,et al.  Stereospecific binding as a tool in attempts to localize and isolate muscarinic receptors. Part II. Binding of (plus)-benzetimide, (minus)-benzetimide and atropine to a fraction from bovine tracheal smooth muscle and to bovine caudate nucleus. , 1974, European journal of pharmacology.

[27]  W. Spector.  The mediation of altered capillary permeability in acute inflammation , 1956 .